ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
COVID-19: Gilead deals with ‘overwhelming’ remdesivir demands, Eli Lilly halts trial enrolment
March 25, 2020As the UK comes to terms with significantly stricter lockdown rules this morning, following prime minister Boris Johnson’s speech last night ... -
Gilead halts emergency access to remdesivir in Covid-19 indication
March 24, 2020Gilead Sciences has announced a temporary halt to emergency access to its investigational Covid-19 drug remdesivir due to rising demand. -
Gilead's Remdesivir Shows Promise in COVID-19
March 16, 2020According to a World Health Organizationofficial, Gilead's experimental antiviral drug remdesivir, to date, shows the most promise for treating COVID-19 disease. -
NIAID Began First Clinical Trial of Remdesivir in the U.S.
March 03, 2020An Investigational New Drug Application (IND) Remdesivir is developed by American drugmaker Gilead Sciences Inc.. -
Experimental antiviral Drug Remdesivir recognized as potential treatment for 2019-nCov
February 10, 2020Remdesivir, an experimental antiviral drug, has been recognized as a potential treatment against the 2019 novel-Coronavirus (2019-nCov) recently outbreaks in China and around the world.
Pharma Sources Insight January 2025
